المؤلفون: Montoro, Maria Julia, Pomares, Helena, Coll, Rosa, Bernal del Castillo, Teresa, Tormo, Mar, Jiménez, Ana, Brunet, Salut, Casaño, Javier, Oiartzabal, Itziar, Díez-Campelo, María, Ramos, Fernando, Romero, Rafael, Salido-Fiérrez, Eduardo, Pedro Olive, Carme, Bargay, Joan, Muñoz-Novas, Carolina, López, Rocío, Rafel, Montserrat, Valcárcel, David, ERASME study group

مصطلحات موضوعية: Real-world evidence, Treatment, High-risk, Clinical practice, Myelodysplastic syndrome

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od______1610::ce002d907c02981ea9e986b1b0ff7924Test
http://hdl.handle.net/10230/56484Test

المؤلفون: Montoro, Maria Julia, Pomares, Helena, Coll, Rosa, Bernal del Castillo, Teresa, Tormo, Mar, Jiménez, Ana, Brunet, Salut, Casaño, Javier, Oiartzabal, Itziar, Díez-Campelo, María, Ramos, Fernando, Romero, Rafael, Salido-Fiérrez, Eduardo, Pedro Olive, Carme, Bargay, Joan, Muñoz-Novas, Carolina, López, Rocío, Rafel, Montserrat, Valcárcel, David, ERASME study group

مصطلحات موضوعية: Clinical practice, High-risk, Myelodysplastic syndrome, Real-world evidence, Treatment

وصف الملف: application/pdf

العلاقة: Leuk Lymphoma. 2023 Mar;64(3):679-90; Montoro MJ, Pomares H, Coll R, Bernal Del Castillo T, Tormo M, Jiménez A, Brunet S, Casaño J, Oiartzabal I, Díez-Campelo M, Ramos F, Romero R, Salido-Fiérrez E, Pedro C, Bargay J, Muñoz-Novas C, López R, Rafel M, Valcárcel D; ERASME study group. Evaluation of the outcomes of newly diagnosed patients with high-risk myelodysplastic syndrome according to the initial therapeutical strategies chosen in usual clinical practice. Leuk Lymphoma. 2023 Mar;64(3):679-90. DOI:10.1080/10428194.2022.215460; http://hdl.handle.net/10230/56484Test; http://dx.doi.org/10.1080/10428194.2022.215460Test

الإتاحة: https://doi.org/10.1080/10428194.2022.215460Test
http://hdl.handle.net/10230/56484Test